Home / Diseases Index / Hepatorenal Syndrome
🩺 Clinical Pathology & Repertory Reference

Hepatorenal Syndrome

Comprehensive Diagnostic & Therapeutic Reference Profile

Also known as: HRS, Hepatorenal Kidney Injury, HRS-AKI, HRS-NAKI

📖
Section 1

Disease Overview

Hepatorenal Syndrome (HRS) is a life-threatening, reversible form of functional renal failure occurring in patients with advanced chronic liver disease, liver failure, or portal hypertension. It is characterized by severe renal vasoconstriction leading to a drastic reduction in glomerular filtration rate (GFR) in the absence of primary histopathological kidney disease.

🏥
Section 2

Medical Classification

Disease Category
Hepatobiliary Disorders
ICD Classification
* ICD-10: K76.7
🧬
Section 3

Etiology & Causes

HRS is caused by severe portal hypertension resulting from liver cirrhosis, alcoholic hepatitis, or acute liver failure. Precipitating factors include:


  • Spontaneous bacterial peritonitis (SBP) or other systemic infections.

  • Gastrointestinal hemorrhage.

  • Large-volume paracentesis (LVP) without adequate volume expansion (intravenous albumin).

  • Overuse of diuretics.

⚙️
Section 4

Pathophysiology

The primary mechanism involves portal hypertension, which triggers arterial vasodilation in the splanchnic circulation, mediated primarily by nitric oxide. This vasodilation leads to a pooling of blood in the splanchnic bed and a decrease in effective arterial blood volume. In response, the body activates compensatory systems: the renin-angiotensin-aldosterone system (RAAS), the sympathetic nervous system (SNS), and antidiuretic hormone (vasopressin). While these systems maintain systemic blood pressure, they trigger profound, compensatory renal vasoconstriction. Over time, renal perfusion falls, lowering GFR and leading to functional renal failure.

📊
Section 5

Epidemiology

  • Prevalence: Occurs in approximately 10% of hospitalized patients with cirrhosis and ascites.
  • Incidence: The 1-year risk of developing HRS in patients with ascites is about 18%, rising to 39% at 5 years.
  • Demographics: No distinct gender or age predilection beyond the baseline demographics of advanced liver disease.
⚠️
Section 6

Risk Factors

  • Decompensated cirrhosis with ascites.
  • Spontaneous bacterial peritonitis (SBP).
  • Active gastrointestinal bleeding.
  • Nephrotoxic drug exposure (e.g., NSAIDs, aminoglycosides).
  • Severe alcoholic hepatitis.
🩺
Section 9

Physical Examination

  • Vitals: Low mean arterial pressure (hypotension), tachycardia.
  • Inspection: Jaundice, scleral icterus, muscle wasting, spider angiomas, palmar erythema, distended abdomen with caput medusae, pedal edema.
  • Palpation: Splenomegaly, fluid wave (ascites), shifting dullness.
  • Auscultation: Decreased breath sounds at the lung bases (pleural effusion).
📷
Section 12

Imaging Studies

  • Renal Ultrasound: Used to assess kidney size, echogenicity, and rule out urinary tract obstruction. Typical findings show normal-sized kidneys without hydronephrosis. Clinically important to exclude post-renal failure and intrinsic chronic kidney disease.
🔀
Section 13

Differential Diagnosis

  • Prerenal Azotemia: Differentiated by rapid improvement of renal function (serum creatinine returning to baseline) within 48 hours of volume expansion with intravenous albumin.
  • Acute Tubular Necrosis (ATN): Characterized by urinary sodium $> 20$ mEq/L, high fractional excretion of sodium (FeNa $> 1\%$), and presence of muddy brown granular casts on urine microscopy.
💢
Section 14

Complications

  • Refractory ascites
  • Severe metabolic acidosis
  • Hyperkalemia
  • Pulmonary edema and pleural effusions
  • Uremic encephalopathy and coma
📉
Section 16

Prognosis

  • Without Treatment: Extremely poor; Type 1 HRS (HRS-AKI) has a median survival of less than two weeks without intervention.
  • With Treatment: Vasoconstrictors and albumin achieve response in about 40–60% of cases.
  • Post-Transplant: Excellent; long-term renal function recovery is expected in the majority of patients who receive a liver transplant.
🛡️
Section 17

Prevention

  • Immediate administration of intravenous albumin in patients diagnosed with Spontaneous Bacterial Peritonitis (1.5 g/kg at diagnosis, followed by 1.0 g/kg on day 3).
  • Prompt discontinuation of diuretics upon sudden worsening of renal function.
🌿
Section 19

Homeopathic Perspective

The following homeopathic remedies have been historically indicated for symptoms associated with Hepatorenal Syndrome. Selection should be based on individualized symptom totality and constitutional assessment.

📝 Clinical Notes:
Learn about Hepatorenal Syndrome (HRS), a severe complication of advanced liver cirrhosis. Explore the causes, diagnostic criteria, life-saving treatments, and prognostic outcomes.
Section 20

FAQs

Q: What is Hepatorenal Syndrome?
Hepatorenal Syndrome (HRS) is a life-threatening, reversible form of functional renal failure occurring in patients with advanced chronic liver disease, liver failure, or portal hypertension. It is characterized by severe renal vasoconstriction leading to a drastic reduction in glomerular filtration...
Q: What are the main symptoms of Hepatorenal Syndrome?
Symptoms vary by individual. Please refer to the Symptoms section above for a detailed list of clinical presentations.
Q: What causes Hepatorenal Syndrome?
HRS is caused by severe portal hypertension resulting from liver cirrhosis, alcoholic hepatitis, or acute liver failure. Precipitating factors include: * Spontaneous bacterial peritonitis (SBP) or other systemic infections. * Gastrointestinal hemorrhage. * Large-volume paracentesis (LVP) without ade...
Q: Which homeopathic remedies are recommended for Hepatorenal Syndrome?
Based on clinical repertory references, recommended remedies include: Arnica, Sulphur, Nux Vomica, Belladonna, Lycopodium. Selection should be individualized based on the patient's complete symptom picture.
Q: When should I see a doctor for Hepatorenal Syndrome?
Consult a healthcare professional if you experience persistent or worsening symptoms, or if the condition significantly impacts your daily activities.
📚
Section 21

References

  • Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
  • Robin Murphy — Lotus Materia Medica (3rd Edition)
  • William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
  • ICD-10/ICD-11 Classification — World Health Organization
  • Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊
Section 22

Clinical Calculator

📊 Advanced Kidney & Renal Function Analyzer

Comprehensive nephrology panel. Calculates eGFR (CKD-EPI 2021 formula), CKD Stage, BUN/Creatinine Ratio, and Creatinine Clearance (Cockcroft-Gault) from a single lab panel.

🧪 Advanced Kidney & Renal Function Analyzer

Comprehensive nephrology panel. Calculates eGFR (CKD-EPI 2021 formula), CKD Stage, BUN/Creatinine Ratio, and Creatinine Clearance (Cockcroft-Gault) from a single lab panel.

Enter your clinical parameters to see dynamic diagnostic readings.

📊 Advanced Kidney & Renal Function Analyzer

Comprehensive nephrology panel. Calculates eGFR (CKD-EPI 2021 formula), CKD Stage, BUN/Creatinine Ratio, and Creatinine Clearance (Cockcroft-Gault) from a single lab panel.

🚀 Open Calculator Page

Clinical Specifications

Reference ID CPD-90195
Disease Group Hepatobiliary Disorders
Content Sections 16 Active Sections

Clinical Consultation

Speak with our specialists for a customized treatment protocol for this condition.

📅 Request Consultation

Medical Disclaimer

This clinical reference is for educational purposes only. It is not a substitute for professional medical diagnosis or treatment. Always consult a licensed healthcare practitioner.

Advertisement
📖 Click any word to see its definition instantly! ×